Christopher Bowden, Chief Medical Officer at AGIOS PHARMACEUTICALS INC (AGIO), sold 3,500 shares at $77.51 ($272K) on 2018-02-16, disclosed to the SEC on 2018-02-20.
Open-market sale of $272k AGIO by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $77.51 | 1,500 | $116K | 42.8% |
| 2 | $77.51 | 1,500 | $116K | 42.8% |
| 3 | $78.08 | 500 | $39K | 14.4% |
| Total | $77.59 avg | 3,500 | $272K | 100% |
| Filing → |
| AGIO | SELL | 2021-06-11 | $3.4M | — | Filing → |
| AGIO | SELL | 2021-06-09 | $1.3M | — | Filing → |
| AGIO | SELL | 2021-04-21 | $1.9M | — | Filing → |